First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
20.05
+1.95 (10.77%)
At close: Apr 28, 2026, 4:00 PM EDT
19.80
-0.25 (-1.25%)
Pre-market: Apr 29, 2026, 8:46 AM EDT
TRAX Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$38.40
Upside
+91.52%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +49.63% | Apr 28, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $46 | Buy | Initiates | $46 | +129.43% | Apr 24, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $31 | Buy | Initiates | $31 | +54.61% | Apr 23, 2026 |
| Barclays | Barclays | Buy Initiates $40 | Buy | Initiates | $40 | +99.50% | Apr 22, 2026 |
| UBS | UBS | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +124.44% | Apr 21, 2026 |